The system can help you get ahead of high and low glucose levels.
Notify you when your glucose is headed towards 70 mg/dL
Notify you when your glucose is headed towards 180 mg/dL
The Guardian™ Connect CGM system was named one of the best continuous glucose monitors in 2021 by CNET. Tech gurus highlight the standout predictive alerts feature: "Unlike other monitors that alert you when your sugar is already high or low, The Guardian [Connect CGM] uses technology that predicts when your blood sugar might get high or low, before it happens." Read the article to see how the Guardian™ Connect system stacks up to others in the market.
Ready to try the system? The Guardian™ Connect CGM1 evaluation program allows you to try out the Guardian™ Connect CGM1 system for $0 out of pocket for 30-days. Terms and conditions apply.
“Predictive alerts let me know what to do ahead of time so I don’t have to take a break.”
wears the Guardian™ Connect system
“This allows me to see how my blood glucose levels are trending so that I can adjust accordingly. It lets me take control of my diabetes. It is my guardian angel.”
wears the Guardian™ Connect system
“I sleep better at night knowing If I go low or high, I will know before it happens and correct for it.∆ Predictive alerts are a must for me.”
wears the Guardian™ Connect system
The Guardian™ Connect CGM system can alert you 30 minutes sooner than other products, giving you more time to react and get ahead of high and low glucose levels††.
The system allows you to customize your alerts. Be notified 10 to 60 minutes before your glucose is out of range. You can also silence alerts if needed plus, choose different settings for day and night.
Continuous glucose monitoring (CGM) systems track glucose levels, every few minutes, 24/7 through a tiny sensor inserted under your skin, either on your belly or arm using an automatic inserter. The sensor measures your interstitial glucose level, which is the glucose found in the fluid between the cells.
Smart CGM predicts future high and low sensor glucose events up to an hour in advance and provides access to information that can inform you of clinically relevant glucose patterns.†
Once we receive your information, we'll start to verify your insurance or pharmacy coverage for the system. A member of our team will reach out to you for additional information. If you have questions please contact us at 888-882-8602 (M-F 9 AM-6 PM CDT).
The Guardian™ Connect continuous glucose monitoring (CGM) system is the standalone CGM system from Medtronic designed from the ground up to help serve the needs of customers on multiple daily insulin injections. Leveraging both modern mobile technology and the latest advances from Medtronic, the Guardian™ Connect system provides a smarter† way to manage your diabetes.
Through the Guardian™ Connect system individuals can:
The Guardian™ Connect system is the only CGM system with customizable predictive alerts that helps you outsmart both highs and lows. Using smart technology to predict where your glucose levels are headed, the system can alert you from 10 to 60 minutes before a high or low.
Exclusively available to people using the Guardian™ Connect system, the Sugar.IQ™ diabetes assistant app (only available on iOS) can continually analyze how glucose levels react to food, exercise and insulin. Together, the Guardian™ Connect system and the Sugar.IQ™ app turn hidden patterns into personalized insights that can help patients make smarter diabetes decisions.1
The Guardian™ Connect system compatibility information can be found by visiting Guardian™ Connect FAQs.You should confirm compatibility with the Guardian™ Connect system using this link before updating your operating system.
The transmitter used with the pump system is different and doesn’t have Bluetooth® connectivity so it isn’t compatible with the Guardian™ Connect app. The MiniMed™ 600-series pumps use the Guardian™ Link 3 transmitter, which uses a different wireless technology to communicate with the pump. The transmitter shell for the Guardian™ Connect system also has a “GC” etched on the surface opposed to the pump system transmitter shell, which just has a “G.”
1. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
2. Guardian™ Connect system SSED, page 19, Table 5. 90.5% Glucose Correct Detection Rate without Predictive Alerts at both 15 and 30 minutes when worn on the abdomen.
3. Guardian™ Connect system SSED, page 19, Table 5. 98.5% Glucose Correct Detection Rate based on Predictive Alerts at 30 minutes when worn on the abdomen.
† Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance.
†† Other CGM's provide predictive alerts up to 30-minutes per respective user guides.
‡ Android is a trademark of Google LLC. iOS is a trademark of Apple Inc.
∆ User interaction required. Individual results may vary.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.
* Alerts must be set to receive predictive alerts.
** Data may not appear or be delayed in certain instances, including when there is no internet connection.
◊ Advanced refers to 60 minute glucose alerts.
§ The patient testimonials above relates an account of an individual’s response to treatment. The account is genuine, typical and documented. However, this patient’s response does not provide any indication, guide, warranty or guarantee as to the response other people may have to the treatment. The response other individuals have to the treatment could be different. Responses to the treatment can and do vary. Not every response is the same. Please talk to your doctor about your condition and the risks and benefits of these technologies.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.